Pomeroy Claire has filed 6 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 22841 shares of Embecta Corp. ($EMBC) on February 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Embecta Corp. | $EMBC | Pomeroy Claire | Director | A | Common Stock | 22841 | $0.00 | 66,127.1640 | 59,290,000 | 52.77% | 0.04% |
| July 24, 2025 | HAEMONETICS CORP | $HAE | Pomeroy Claire | Director | A | Common Stock | 2693 | $0.00 | 16,872.0000 | 50,730,000 | 18.99% | 0.01% |
| Feb. 12, 2025 | Embecta Corp. | $EMBC | Pomeroy Claire | Director | A | Common Stock | 13839 | $0.00 | 41,289.1530 | 58,622,000 | 50.42% | 0.02% |
| July 25, 2024 | HAEMONETICS CORP | $HAE | Pomeroy Claire | Director | A | Common Stock | 2207 | $0.00 | 14,179.0000 | 51,397,000 | 18.43% | 0.00% |
| Feb. 7, 2024 | Embecta Corp. | $EMBC | Pomeroy Claire | Director | A | Common Stock | 11455 | $0.00 | 26,443.8580 | 57,758,000 | 76.42% | 0.02% |
| Feb. 9, 2023 | Embecta Corp. | $EMBC | Pomeroy Claire | Director | A | Common Stock | 6979 | $0.00 | 14,631.6279 | 0 | 91.20% | 0.00% |